Management of Acute Bronchitis in Otherwise Healthy Adults
Do not prescribe antibiotics, antivirals, antitussives, inhaled beta-agonists, inhaled anticholinergics, inhaled or oral corticosteroids, or NSAIDs for routine management of acute bronchitis in immunocompetent adults. 1, 2
Initial Assessment: Rule Out Pneumonia
The primary objective when evaluating acute bronchitis is excluding pneumonia, which requires different management. Pneumonia is highly unlikely if ALL of the following are absent: 2
- Tachycardia (heart rate >100 beats/min)
- Tachypnea (respiratory rate >24 breaths/min)
- Fever (oral temperature >38°C)
- Abnormal chest examination findings (rales, egophony, tactile fremitus)
If these vital sign abnormalities and examination findings are absent, no chest X-ray or laboratory testing is needed 1, 2.
Understanding the Disease Process
Acute bronchitis is viral in more than 90% of cases 2. The cough typically lasts 2-3 weeks and is self-limited 3. This understanding is critical for patient education and managing expectations.
Important caveat: The presence of purulent (green or yellow) sputum does NOT indicate bacterial infection—it simply reflects inflammatory cells and sloughed epithelial cells 2. This is a common pitfall leading to unnecessary antibiotic prescriptions.
Evidence-Based Treatment Approach
What NOT to Do
The 2020 CHEST Expert Panel provides the strongest guidance against routine pharmacologic interventions 1:
- No antibiotics: Studies show no significant difference in cough duration between antibiotics and placebo (11 days vs 11 days for amoxicillin-clavulanic acid vs placebo) 1. Antibiotics increase adverse events without clinical benefit 2.
- No NSAIDs: Ibuprofen showed no benefit over placebo (9 days vs 11 days of cough) 1.
- No inhaled bronchodilators: Beta-agonists do not benefit patients without underlying asthma or COPD 2.
- No corticosteroids (inhaled or oral): Insufficient evidence of benefit 1.
What TO Do
Primary management consists of:
- Patient education: Explain that cough will last 2-3 weeks and is self-limited 3
- Symptomatic relief options (though evidence is limited): Over-the-counter cough suppressants (dextromethorphan, codeine), expectorants (guaifenesin), first-generation antihistamines (diphenhydramine), or decongestants (phenylephrine) may provide modest symptom relief 2
- Reassurance: Describe the condition as a "chest cold" to align patient expectations 3
When to Reconsider: The Exception
If symptoms worsen or fail to improve, reassess the patient. Consider antibiotics ONLY if a complicating bacterial infection becomes likely 1. This requires clinical judgment based on:
- Worsening rather than improving symptoms beyond expected timeline
- Development of new fever or vital sign abnormalities suggesting pneumonia
- Consideration of alternative diagnoses (COPD exacerbation, asthma, bronchiectasis) that may require different management 1
Communication Strategy to Reduce Antibiotic Prescribing
The American College of Physicians and CDC recommend 2:
- Delayed prescriptions: Provide a prescription but instruct patients to fill it only if symptoms worsen significantly
- Reframe the diagnosis: Use "chest cold" terminology rather than "bronchitis" to reduce antibiotic expectations 3
- Set realistic expectations: Emphasize the 2-3 week cough duration upfront
Special Consideration: Pertussis
Consider pertussis (Bordetella pertussis) when there is known community transmission or cough persisting beyond 2-3 weeks 2. In these cases, testing and antibiotic treatment may be warranted to reduce transmission, not to improve individual outcomes.
Quality of Care Metrics
High-value care means avoiding unnecessary testing and treatment 2. The evidence consistently demonstrates that antibiotics expose patients to adverse effects (nausea, diarrhea, allergic reactions, antibiotic resistance) without meaningful clinical benefit in uncomplicated acute bronchitis 2.